Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1108-1117

  Kuhn, Eric ^a   Addona, Terri ^a   Keshishian, Hasmik ^a   Burgess, Michael ^a   Mani, D R ^a   Lee, Richard T ^b   Sabatine, Marc S ^b   Gerszten, Robert E ^c   Carr, Steven A ^a  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 33; PEPTIDE; PEPTIDE ANTIBODY; PROTEIN; TROPONIN I; TRYPSIN;

ACCURACY; ANTIBODY AFFINITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART INFARCTION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMMUNOASSAY; ISOTOPE DILUTION ASSAY; MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; PLASMA; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; STANDARD; TECHNIQUE;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; HUMANS; INTERLEUKINS; PEPTIDES; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TROPONIN I;

EID: 66449083773     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.123935     Document Type: Article

References (40)

1. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nature Biotechnol 2006;24:971-983 (Pubitemid 44215392)
2. Carr SA, Anderson L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin Chem 2008;54:1749-1752
3. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006;5:573-588
4. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007;6:2212-2229
5. 13C-labeled peptide standards. Proteomics 2004;4:1175-1186
6. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 2007;53:673-678 (Pubitemid 46580237)
7. Paulovich AG, Whiteaker JR, Hoofnagle AN, Wang P. The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline. Proteom Clin Appl 2008;2:1386-1402
8. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867
9. Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG, et al. Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol 2008;295:L16-22.
10. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J Proteome Res 2004;3:235-244 (Pubitemid 38500990)
11. Whiteaker JR, Zhao L, Zhang HY, Feng LC, Piening BD, Anderson L, Paulovich AG. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 2007;362:44-54. (Pubitemid 46198803)
12. Adams JE 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101-106
13. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992;38:2203-2214
14. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-1549 (Pubitemid 46871338)
15. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-2081 (Pubitemid 27184276)
16. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214 (Pubitemid 26001850)
17. Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 2003;75:663-670 (Pubitemid 36176744)
18. Currie LA. Limits for qualitative detection and quantitative determination. Anal Chem 1968;40:586-593
19. Linnet K. Evaluation of regression procedures for methods comparison studies. Clin Chem 1993;39:424-432 (Pubitemid 23099007)
20. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 2008;118:3503-3512
21. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008;54:1796-1804
22. Christenson RH, Duh SH, Apple FS, Bodor GS, Bunk DM, Dalluge J, et al. Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin Chem 2001;47:431-437 (Pubitemid 32222456)
23. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088-3096 (Pubitemid 43113440)
24. Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008;7:827-840
25. Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 2008;117:1936-1944
26. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem 2002;48:2008-2016 (Pubitemid 35222759)
27. Kaplan IV, Levinson SS. When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clin Chem 1999;45:616-618 (Pubitemid 29220321)
28. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lovgren T, Severina ME, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-1385 (Pubitemid 27329785)
29. Shi Q, Ling M, Zhang X, Zhang M, Kadijevic L, Liu S, Laurino JP. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. Clin Chem 1999;45:1018-1025 (Pubitemid 29340539)
30. Zimmer D. Introduction to quantitative liquid chromatography-tandem mass spectrometry (LCMS-MS). Chromatographia 2003;57:S325-32. (Pubitemid 36609433)
31. Nichkova M, Dosev D, Gee SJ, Hammock BD, Kennedy IM. Multiplexed immunoassays for proteins using magnetic luminescent nanoparticles for internal calibration. Anal Biochem 2007;369:34-40. (Pubitemid 47313379)
32. Nicol GR, Han M, Kim J, Birse CE, Brand E, Nguyen A, et al. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol Cell Proteomics 2008;7:1974-1982
33. Berna M, Ott L, Engle S, Watson D, Solter P, Ackermann B. Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy. Anal Chem 2008;80:561-566
34. Berna MJ, Zhen Y, Watson DE, Hale JE, Ackermann BL. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal Chem 2007;79:4199-4205 (Pubitemid 46903173)
35. Labugger R, Simpson JA, Quick M, Brown HA, Collier CE, Neverova I, Van Eyk JE. Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem 2003;49:873-879 (Pubitemid 36623465)
36. 15N-isotopically labeled albumin internal standard. Clin Chem 2007;53:540-542
37. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-116
38. Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, et al. Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy 2008;38:1875-1881
39. Martosella J, Zolotarjova N, Liu H, Nicol G, Boyes BE. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J Proteome Res 2005;4:1522-1537 (Pubitemid 41464777)
40. Liu T, Qian WJ, Mottaz HM, Gritsenko MA, Norbeck AD, Moore RJ, et al. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics 2006;5:2167-2174 (Pubitemid 44817028)